Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men.
暂无分享,去创建一个
M. Bottai | E. Ingelsson | L. Lind | J. Ärnlöv | A. Larsson | A. Carlsson | J. Sundström | T. Larsson | A. Larsson | J. Helmersson-Karlqvist | L. Lind
[1] A. Newman,et al. Association of urinary injury biomarkers with mortality and cardiovascular events. , 2014, Journal of the American Society of Nephrology : JASN.
[2] L. Lind,et al. Kidney injury molecule (KIM)-1 is associated with insulin resistance: results from two community-based studies of elderly individuals. , 2014, Diabetes research and clinical practice.
[3] M. Bottai,et al. Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation – a cohort study from Sweden using propensity score analyses , 2014, Diabetology & Metabolic Syndrome.
[4] R. Vasan,et al. Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes. , 2013, Journal of the American Society of Nephrology : JASN.
[5] Josef Coresh,et al. Cystatin C versus creatinine in determining risk based on kidney function. , 2013, The New England journal of medicine.
[6] A. McMahon,et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. , 2013, The Journal of clinical investigation.
[7] E. Ingelsson,et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. , 2013, Atherosclerosis.
[8] E. Ingelsson,et al. Urinary kidney injury molecule 1 and incidence of heart failure in elderly men , 2013, European journal of heart failure.
[9] D. Siscovick,et al. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] E. Barrett-Connor,et al. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. , 2012, Journal of the American College of Cardiology.
[11] L. Tavazzi,et al. Clinical outcome of renal tubular damage in chronic heart failure. , 2011, European heart journal.
[12] M. Mack,et al. Kidney injury molecule‐1 and N‐acetyl‐ß‐d‐glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome , 2011, European journal of heart failure.
[13] E. Ingelsson,et al. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] J. Ludvigsson,et al. External review and validation of the Swedish national inpatient register , 2011, BMC public health.
[15] G. Lip,et al. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. , 2011, Journal of the American College of Cardiology.
[16] G. Navis,et al. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] R. Bellomo,et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. , 2011, Journal of the American College of Cardiology.
[18] H. Stopper,et al. Mineralocorticoid receptor‐mediated DNA damage in kidneys of DOCA‐salt hypertensive rats , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] J. Bonventre,et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. , 2011, Kidney international.
[20] G. Navis,et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate , 2010, Heart.
[21] W. Huo,et al. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. , 2010, Transplantation reviews.
[22] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[23] C. Cheadle,et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. , 2010, American journal of physiology. Renal physiology.
[24] Joseph V Bonventre,et al. Next-generation biomarkers for detecting kidney toxicity , 2010, Nature Biotechnology.
[25] S. Bakker,et al. Kidney injury molecule‐1 in renal disease , 2010, The Journal of pathology.
[26] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[27] J. Bonventre. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[28] J. Ärnlöv. Diminished Renal Function and the Incidence of Heart Failure , 2009, Current Cardiology Reviews.
[29] C. Held,et al. Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community , 2009, Circulation.
[30] J. Árnlöv. Diminished renal function and the incidence of heart failure. , 2009, Current cardiology reviews.
[31] G. Navis,et al. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] R. Kain,et al. Kim-1/Tim-1: from biomarker to therapeutic target? , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] J. Bonventre,et al. Biomarkers of acute kidney injury. , 2008, Annual review of pharmacology and toxicology.
[34] R. Gans,et al. High Urinary Excretion of Kidney Injury Molecule-1 Is an Independent Predictor of Graft Loss in Renal Transplant Recipients , 2007, Transplantation.
[35] L. Wilhelmsen,et al. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up , 2007, Journal of hypertension.
[36] M. C. V. D. Heuvel,et al. Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.
[37] J. Thurman. Triggers of inflammation after renal ischemia/reperfusion. , 2007, Clinical immunology.
[38] B. Jaber,et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. , 2007, Journal of the American Society of Nephrology : JASN.
[39] L. Hansson,et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L , 2004, Scandinavian journal of clinical and laboratory investigation.
[40] A. Dyer,et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. , 2003, JAMA.
[41] A. Dyer,et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .
[42] M Soledad Cepeda,et al. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. , 2003, American journal of epidemiology.
[43] J. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.
[44] P. McKeigue,et al. Changes in physical activity are associated with changes in metabolic cardiovascular risk factors , 2001, Diabetologia.
[45] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[46] Joseph V. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.
[47] D. Lin,et al. Non-parametric inference for cumulative incidence functions in competing risks studies. , 1997, Statistics in medicine.